Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934564 · ClinicalTrials.gov registry record · NA
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
A NA study of Laparoscopic Cholecystectomy and Inguinal Hernia Repair, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06934564: Recruiting NA study of Laparoscopic Cholecystectomy and Inguinal Hernia Repair, sponsored by University of Michigan.
NCT06934564 is a NA study of Laparoscopic Cholecystectomy and Inguinal Hernia Repair that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 16 participants, below the 316-participant average among 4 other Laparoscopic Cholecystectomy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934564, a NA study of Laparoscopic Cholecystectomy and Inguinal Hernia Repair, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
Primary Outcome
Only tests relating to three index procedures; breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair Data collected using MVC/MSQC database
Conditions Studied
Interventions
- BEHAVIORAL Active de-Implementation
Study Locations (1)
Michigan
- University of Michigan and other Michigan Surgical Quality Collaborative sites - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06934564 shows while recruiting
NCT06934564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 316-participant average among 4 other Laparoscopic Cholecystectomy trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Laparoscopic Cholecystectomy appearing as the primary indexed condition, and to 1 intervention - of which Active de-Implementation is the first listed.
NCT06934564 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06934564 about?
NCT06934564 is a clinical study titled "De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery". This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have be...
What is the current status of trial NCT06934564?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-04-01. Estimated completion is 2026-12.
What conditions does trial NCT06934564 study?
This clinical trial studies the following conditions: Laparoscopic Cholecystectomy, Inguinal Hernia Repair, Breast Lumpectomy.
What interventions are being tested in trial NCT06934564?
The interventions under investigation include: Active de-Implementation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06934564?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934564 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laparoscopic Cholecystectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nerve Blocks vs Local Injections for Post-op Pain Prevention in Laparoscopic Cholecystectomy in Children
COMPLETED · NA
-
Laparoscopic Cholecystectomy Care Protocol
COMPLETED
-
A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain
COMPLETED · Phase 3
-
Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI